JFL Life Science IPO Guidance & Details

JFL Life Science IPO Listing on 8 September 2022
Issued at Rs. 61
Listed at Rs.70
Day high Rs. 70
Closed at Rs. 66.50

Grey Market News for JFL Life Science IPO #
On 8 September 2022
Grey Market Premium:  Rs. 1 seller

Subscription Trend
On 30 August 2022 @ 5.00 pm
NII (50%): 6.19 T
RII (50%): 11.66 T
Total shares: 8.93 T

JFL Life Science IPO Details
IPO Date August 25, 2022 to August 30, 2022
IPO Face Value Rs 10 per share
IPO Price Rs 61 per share
IPO Lot Size 2000 Shares
Issue Size 2978,000 shares of Rs 10
(aggregating up to Rs 18.17 Cr)
Fresh Issue 2978,000 shares of Rs 10
(aggregating up to Rs 18.17 Cr)
Issue Type Fixed Price Issue IPO
Listing At NSE SME
Retail Shares Offered 50% of the net offer
NII (HNI) Shares Offered 50% of the net offer

Retail Quota : 50 % / 1489,000 Shares
Minimum  2000 Rs 122,000
Maximum  2000 Rs 122,000
Retail : 745 Applications required for one time subscriptions.

JFL Life Science IPO Timetable 
IPO Opening Date August 25, 2022
IPO Closing Date August 30, 2022
Basis of Allotment Sept 2 , 2022
Initiation of Refunds Sept 5, 2022
Credit of Shares to Demat Sept 6, 2022
IPO Listing Date Sept 7, 2022

JFL Life Science Business :

Headquartered in Ahmedabad, Gujarat, JFL Life Science is engaged in the business of manufacturing of pharmaceutical products. Its product portfolio consists of Dry powder injections ( B-Lactam ), Tablets & Capsules (B-Lactam) solid oral dosage form and Tablet and capsules (general) Solid Oral Dosage Form and Oral rehydration solutions (ORS).
The company is engaged in domestic as well as international business. With market presence in PAN India, products of JFL is supplied to 10 developed and developing countries throughout the World.

To maintain its competitiveness and to further the cause of health care JFL has laid a strong R&D foundation and a FDA approved state of the art manufacturing facility near Ahmedabad. It is a manufacturing company, so its sales strategy is to sell its products in bulk to pharmaceuticals marketers and traders who in turn provide the channel for sales to customers. It doesnot sell it under any brand name and it use the same strategy for both domestic & international market.

The Company exports its products majorly to African countries, Middle Eastern countries and CIS countries, mainly through merchant exporters. The Company is registered with the MOH of Kenya, Nigeria, Yemen, Cambodia & Myanmar for manufacturing of a particular product. Few of its products are also registered with Ukraine, Uzbekistan, Kazakhstan (CIS countries) through merchants.
For more information about the company,Click www.jfllifesciences.com

Promoters of JFL Life Science

Smiral Ashwinkumar Patel and Tejal Smiral Patel

JFL Life Science : Objects of the IPO
Repayment of secured and unsecured loans.
Funding the working capital requirements of the company.

Registered office of JFL Life Science
309, Satyam Mall,Opp. Saman Complex, Nr. Vishweshwar Mahadev Mandir
Settelite, Ahmedabad 380015
Company Secretary and Compliance Officer: Pratima Singh

Lead Manager of JFL Life Science IPO
GYR Capital Advisors ltd

SME IPO Financial & Analytical Ratios#
Earnings per Share 2019-20 Rs 0.66
Earnings per Share 2020-21 Rs 0.89
Earnings per Share 2021-22  11M Rs 3.77
Return on Net Worth: 19-20: 6.70 %
Return on Net Worth: 20-21 : 7.89 %
Return on Net Worth: 21-22 11M : 25.20 %
Book Value of the Share as on 28.2.22 Rs 13.67
NAV after the IPO Rs.-
Offer Price Rs. 61

IPO Peer Comparison:
Zenith Health Care @ PE Multiple of 115.86
Vaishali Pharma @ PE Multiple of 21.34

Observation by Paresh Gordhandas ( Research Analyst )

For Guidance : Will be updated soon

# This is only coverage of News related to Grey Market . We donot deal in Grey market premium or Subject to rates, nor we recommend dealing in Grey Market. Investment decision based on Grey Market trends can be faulty.